Exam One Flashcards

1
Q

True or False: The United States and Indiana operate as both a democracy and a republic

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Democracy

A

a government in which the supreme power is vested in the people and exercised by them directly or indirectly through a system of representation usually involving periodically held free elections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Republic

A

a government in which supreme power resides in a body of citizens entitled to vote and is exercised by elected officers and representatives responsible to them and governing according to law

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Federally, how are all citizens represented?

A
  • Two US State Senators (6 year term)
  • One US State Representatives (2 year term)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In Indiana, how are all citizens represented?

A
  • One Indiana State Senator (4 year term)
  • One Indiana State Representative (2 year term)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How long is each federal congress convened over?

A

a rolling two year term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True or False: Bills carried can be carried over from the first session?

A
  • Yes
  • must be passed by the end of the second session
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What type of legislature is Indiana?

A
  • Citizen’s legislature
  • lawmaking is not a full-time profession in Indiana
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the General Assembly?

A
  • legislative body of Indiana consisting of senators and representatives
  • two sessions over two years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How long is a long session?

A

61 days, ends by April 30th

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How long is a short session?

A

30 days, ends by March 15th

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Statute

A

a written law enacted by the legislature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where is federal law listed?

A

United States Code

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where is Indiana law listed?

A

Indiana Code (IC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Regulation

A

a rule having the force of law issued by an administrative agency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which two agencies issue federal rules or regulations related to pharmacy?

A

FDA and DEA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Where are federal regulations listed?

A

Code of Federal Regulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Where are Indiana regulations listed?

A

Indiana Administrative Code

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How to cite Federal Statues and Rules

A

Title USC/CFR Section(subsection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How to cite Indiana Code

A

IC Title-Article-Chapter-Section

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How to cite Indiana Administrative Code

A

Title IAC Article-Chapter(Rule)-Section

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Criminal Action

A

you break the law and are punished by the state or federal government, traditionally through fines or jail time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Civil Action

A

a private party sues another party because they believe they have been harmed by something that was done in an attempt to receive restitution (payment) for the act

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Administrative Action

A

a professional (like a pharmacy) violates a law or regulation, and an administrative agency (like the board of pharmacy) investigate and may restrict licensure or abilities to act under a license

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What drug developed in 1952 given to pregnant women caused fetal malformations?

A

Thalidomide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What amendment was passed largely in result of the thalidomide disaster

A

Kefauver-Harris Amendment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What did the Kefauver Harris Amendment require?

A
  • required all meds to be demonstrated as not only safe, but also effective (drugs marketed between 1938-1962 and new drugs)
  • transferred jurisdiction of prescription drug advertising from FTC to FDA
  • established cGMP requirements
  • added requirements to clinical investigations including informed consent and adverse drug reaction reporting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Which amendment established cGMP requirements?

A

Kefauver Harris Amendemnt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Which amendment transferred jurisdiction of drug advertising from FTC to FDA?

A

Kefauver Harris Amendment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the minimum requirements for the manufacturing processes of drug products according to cGMP?

A
  • design
  • monitoring
  • control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How often does a FDA registered drug manufacturer undergo inspection according to cGMP?

A

at least once every 2 yeaars

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What happens to the drug if a manufacturer does not comply with cGMP

A

the drug is alduterated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What happens to the drug if a manufacturer does not register with the FDA?

A

the drug is aldulterated and misbranded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the three general categories of drug making

A
  • pharmacy or traditional compounding (503a)
  • outsourcing facilities (503b)
  • manufacturing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

503a

A
  • pharmacy or traditional compounding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What category would compounding according to prescriptions specific to particular patients on as a needed basis fall under

A

503a compounding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

503b

A
  • outsourcing facility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What category would manufacturing large batches with or without prescriptions to be sold to facilities for office use only fall under?

A

503b compounding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What is manufacturing

A

mass production of drug products that have been approved by the Food and Drug Administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is required for something to be considered 503 a compounding?

A
  • compound pursuant to prescription only
  • for an individual person
  • bulk substances comply with USP-NF
  • compound cannot be copy of commercially available product
  • can be done in advance on a limited basis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Can you compound commercially available products under a 503a pharmacy?

A
  • no, unless there is a drug shortage (on FDA list)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What requirements are 503a pharmacies exempt from?

A
  • cGMP
  • misbranding (related to drug labeling)
  • New Drug Requirements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Do you need a prescription for a 503b pharamcy?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What is required of a 503b pharmacy?

A
  • must register, pay annual fees, and be inspected by FDA
  • compounding cannot be a copy of commercially available product
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What is required on a 503b product label

A
  • “This is a compounded drug”
  • Name, address, phone number of the outsourcing facility
  • lot number or batch number
  • established name of the drug
  • dosage or strength
  • quantity or volume
  • BUD
  • storage and handling instructions
  • NDC
  • “Not for resale”
  • list of active and inactive ingredients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Drug manufacturers are not exempt from what?

A
  • misbranding
  • cGMP
  • and new drug requirements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What are outsourcing facilities (503b) exempt from

A
  • new drug requirements
  • misbranding if labeling/packaging requirements are not there
  • need cGMP!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What are grandfathered drugs?

A
  • drug that was introduced before 1938 and was still on the market in 1962
  • assumed safe for use and effective based on their longevity on the market
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What are DESI drugs?

A
  • drugs that entered the market between 1939 and 1962
  • were assumed to be safe but not considered effective
  • drugs were a part of dESI program where they were in studies to prove their efficacy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

True/False: products a part of DESI were allowed to stay on the market until a decision was made

A

yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What describes step one of the drug development process?

A
  • Preclinical Research
  • In vivo animal testing utilized to record data on toxicity and pharmacology of the product
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

What describes step two of the drug development process?

A
  • Investigational New Drug
  • Once IND has been submitted, sponsor must wait 30 days before initiating any clinical trials to allow the FDA to review the IND
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

If a drug shows the possibility for safe and effective use, what can the manufacturer submit?

A

an IND

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What information does the IND have to contain?

A
  • animal pharmacology and toxicology studies
  • manufacturing information
  • clinical protocols and investigator information
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

what describes step three of the drug development processes

A

clinical research phases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

What are reviewed and reported in phase 1?

A

baseline human PK and pharmacological properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What percent of drugs move on to phase 2?

A

70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Who is included in phase 1?

A
  • 20-100 healthy human volunteers receive the drug to evaluate the safety and dosage of the compound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Who is included in phase 2?

A

several hundred human volunteers who have the disease or condition that is being studied

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What is the primary goal of phase 2?

A

expand information about safety and adverse effects of the drug, and to determine the effectiveness of the therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Who is included in phase 3?

A

hundreds or thousands of patients in several geographical locations who have the disease or condition that is being treated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

What is the goal of phase 3?

A
  • demonstrate efficacy at a higher power, and to expand information around adverse effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What is step 4 of the drug development process?

A

New Drug Application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Where is the NDA submitted to?

A

the sponsor submits to the FDA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

What needs to be included in the NDA

A
  • everything from preclinical data to phase 3 trial data
  • proposed labeling
  • safety updates
  • drug abuse information
  • patent information
  • any data from studies that may have been conducted outside the US
  • institutional review board compliance information
  • directions for use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

How long can it take the FDA to review an NDA

A

6-10 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

What is step five of the drug development process?

A
  • post marketing surveillance through MedWatch
  • adverse events reported by health professionals and patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Which act provided lower statistical burdens for proof of safety for drugs indicated for rare diseases?

A

Orphan Drug Act of 1983

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

What did the Orphan Drug Act allow?

A
  • tax incentives for orphan drug production
  • enhanced patent protection and marketing
  • clinical research subsidies
  • government incentive to engage in drug research
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

What led to the development of the Orphan Drug Act

A
  • due to the Kefauver Harris Amendment, medications became costly to develop
  • most drug manufacturers only developed medications for common disease states to ensure they could recoup developmental costs and maintain profitability
  • rare diseases were ignored
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Which act was passed to reduce requirements for approval of generic prescription drugs?

A

1984 Hatch Waxman Act

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Why was the Hatch Waxman act passed?

A

to reduce requirements for approval of generic prescription drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

What does the Hatch Waxman Act allow?

A
  • generic companies can prepare for approval without impinging on patent
  • only had to prove bioequivalence and proof of acceptable manufacturing practices and controls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

What is the Abbreviated New Drug Application

A

pathway for generic drug approval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Which act led to the abbreviated NDA

A

Hatch Waxman Act

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Why is the abbreviated NDA termed abbreviated?

A

applicant does not need to include animal or human clinical trial data to establish safety and efficacy, only bioequivalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

What is bioequivalence

A

demonstration that rate of absorption of the generic drug is equivalent to the innovator drug (must deliver the same amount of ingredient in the same amount of time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Which act requires prescription drugs to be packaged in child resistant containers or special packaging?

A

1970 Poison Packaging Act (PPPA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

What is Special Packaging?

A
  • targeting at kids under 5 years old
  • not difficult for normal adults to access
  • most kids under 5 should struggle to open, and those that can open it will be prevented from obtaining a toxic amount in a reasonable time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

What does the PPPA apply to

A

only oral drugs!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Child resistant means ___% of children or less can open after ___ minutes

A

20,10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

At least __% of adults can open CRC after ___ minutes

A

90, 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

What are considered covered products under the PPPA

A
  • drugs for oral administration require special packaging
  • OTC and prescription drugs, controlled substances, and samples
  • drugs intended to be dispensed in manufacturers packaging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

What products do not need special packaging

A

bulk products and unit dose containers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

If dispensing a bulk product or unit dose product and it is not in an appropriate CRC, what is the drug considered

A

misbranded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

What are the exemptions to special packaging

A
  • non-oral dosage forms
  • waivers
  • consumer product safety commission exemption (23 product)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Prescription by prescription wavers

A
  • can be given by prescribers and patients
  • waives CRC packaging for the life of a single prescription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Blanket waviers

A
  • patient authorization only
  • waives CRC packaging for all products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Notable CPSC Exemptions

A
  • sublingual nitroglycerin
  • oral contraceptives in mnemonic dispenser packages
  • steroid dose packs
  • some oral powder formulations
  • unit dose potassium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

When can you reuse packaging

A
  • only if its in a glass vial and a new cap is used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

What is a recall

A

the correction or removal and notification to the company of a product which is in violation of the law

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Class I Recall

A

drug product may cause serious adverse health consequences including death (pharmacies notify patients who receive recalled drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Class II recall

A
  • drug may cause temporary or reversible side effects, but probability of serious health consequence is remote
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Class III recall

A

drug product is unlikely to cause serious adverse health consequences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

FDA seizure

A

FDA may physically isolate a drug thta is adulterated or misbranded while a civil lawsuit is filed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

DEA Seizure

A

DEA may physically isolate a drug that is illegal to possess or distribute while a criminal lawsuit is filed, with probable cause and a warrant when necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

True or False: A drug recall is not voluntary

A

FALSE, a drug recall is voluntary, a seizure is not

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

What act was passed after the chicago tylenol murders?

A

Federal Anti-Tampering Act

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

What is the basis of the federal anti-tampering act

A
  • makes tampering a federal crime
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

What is considered tamper evident packaging

A
  • must have indicators or barriers to entry which, if breached or missing, can reasonably be expected to provide visible evidence to consumers that tampering has occurred
  • product must be distinctive by design and not be able to be dublicated with
  • any two piece hard gelatin capsule must be sealked
  • tamper evident features must be described on the packaging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

If packaging does not have tamper evident technology, then the drug is considered what?

A

misbranded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

What is the label

A

any printed, written, or graphic material on the product container (not the Rx label)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

what is labeling

A

all labels and written, printed, or graphic material on the container, container wrapper, or accompnaying the product

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

True or False: labeling includes anything accompanying the product, including advertisements and spoken words by drug reps

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

What is a package insert

A

required as part of the labeling of prescription drugs and biological products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Are package inserts intended for healthcare professionals or patients

A

healthcare professionals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

If a drug on a self does not have a package insert, it is considered what

A

misbranded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

What are the 3 reproductive categories?

A
  • pregnancy
  • lactation
  • females and males of reproductive potential
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

What are patient package inserts

A

FDA approved labeling written in patient friendly language which covers drug uses, risks, and precautions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Is it required to dispense a PPI with the drug to a patient?

A

YES, if not it is misbranding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

What drugs require PPIs

A

estrogens and oral contraceptives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

What are MedGuides

A

FDA approved labeling written in patient friendly language that explains issues related to a drug or drug class

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

When to dispense MedGuides

A

must be provided with new and refill prescriptions for patients in an outpatient environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

When are MedGuides Required

A
  • labeling could help prevent serious adverse effects
  • serious risks of use exist which patients should be made aware of
  • patient adherence to directions is crucial to drug effectivness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Failure to dispense a MedGuide deems the drug what?

A

misbranded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

What are the four types of REMS

A
  • patient friendly labeling
  • communication plans
  • elements to assure safe use
  • implementation system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Patient friendly labeling

A
  • med guides and PPIs
118
Q

Communication plans

A

info sent directly to healthcare practioners informing them about the drug and how to mitigate issues for the patients

119
Q

ETASU

A

required activities that must be done before prescribing, dispensing, or receiving a product

120
Q

Implementation System

A

a quality assurance process to ensure that risks are being mitigated successfully

121
Q

Does consumer medical information replace formal counseling done by pharmacists?

122
Q

What is required on the drug facts OTC labeling

A
  • active ingredients
  • purpose
  • use
  • warning
  • directions
  • inactive ingredients
  • other information
123
Q

In addition to the drug Facts label, what else does an OTC label need to have?

A
  • expiration date when applicable
  • lot or batch code
  • name and address of manufacturer, packer, or distributor
  • net quantity of contents
  • a descriptions of the type of tamer-evident packaging utilized
124
Q

Which MedWatch form do health professions fill out

A

FDA Form 3500

125
Q

Which MedWatch form do patients fill out

126
Q

Purpose of MedWatch

A

to report serious adverse events associated with drugs or FDA covered products

127
Q

Who are the Big Four prescribers?

A
  • physicians (MD/DO)
  • dentists (DDS, DMD)
  • podiatrists (DPM)
  • veterinarians (DVM)
128
Q

What are full prescribers?

A
  • prescriptions from full prescribers are honored in any part of the United States as long as they are licensed in at least one jurisdiction of the US
129
Q

What are examples of mid-level prescribers?

A
  • NPs
  • PAs
  • Optometrists
  • Pharmacists
130
Q

Describe the extent to which prescriptions from mid-level prescribers are honored?

A
  • do not necessarily have authority to prescribe across all states
  • may not be honored in all jurisdictions
131
Q

What can physicians prescribe for?

A
  • whole body authority for humans
132
Q

What can dentists prescribe for?

A
  • mouth
  • maxillofacial area for humans
133
Q

What can podiatrists prescribe for?

A
  • feet
  • ankle
  • sometimes hands for humans
134
Q

What can veterinarians prescribe for?

A
  • whole body authority for all animals
135
Q

Scope of Practice vs Speciality Practice

A
  • Scope of Practice: can prescribe based on licensure (dermatologist is an MD, so technically can prescribe for URI since MD has authority over all human body)
  • Specialty Practice: subset speciality of authority
136
Q

What is Agency Law?

A
  • utilized when a prescriber authorizes an agent to deal with a third party
  • nurse or MA calling in a prescription on behalf of the prescriber
137
Q

What cant an agent do?

A
  • make decisions on behalf of the prescriber
138
Q

Are there federal uniform standards for non-controlled prescriptions in the US?

139
Q

Does federal law address prescription expiration or refills?

140
Q

What does the federal government address about prescriptions?

A

requirements of prescription labels

141
Q

What is always required on prescriptions labels to be exempt from misbranding?

A
  • the name and address of dispenser
  • the prescription number
  • the date of the prescription or its filling
  • the name of the prescriber
142
Q

What should be on the prescription label if given?

A
  • name of the patient
  • any directions for use
  • any cautionary statements
143
Q

True or False: the prescription label must have the name of the pharmacy

A

FALSE! must have name of the dispenser (central fill pharmacy must list the final pharmacy address, not its own address)

144
Q

How long can an OTC or Rx, non-control prescription be refilled?

145
Q

How many refills are allowed for otc and rx only non controled substances

146
Q

How long can a OTC or RX only CIII-CV be refilled

A

six months

147
Q

How many refills can a OTC or RX only CIII-CV have

148
Q

How long can a Rx prescription be refilled

149
Q

How many refills are allowed for and RX only CII

A

not refillable

150
Q

What law targeted spending on medications by Medicaid beneficiaries?

A

OBRA ‘90

151
Q

What are the four primary requirements of OBRA ‘90

A
  • Prospective DUR
  • Retrospective DUR
  • Off to conduct patient counseling
  • maintaining patient records
152
Q

What is a prospective DUR

A
  • pharmacist must review drug therapy before each prescription is filled for accuracy and appropriateness
153
Q

What is a retrospective DUR

A
  • states must review medication use of drugs and compare how they are being used against acceptable standards
154
Q

What is required of pharmacists in terms of patient counseling in regards to OBRA ‘90

A
  • law requires an offer to have a pharmacist counsel the patient be made
  • this only applies to Medicaid patients
  • nothing requires consultation when an individual refuses such consulations
155
Q

What does OBRA ‘90 say about patient records?

A
  • a reasonable effort must be made by the pharmacist to obtain, record, and maintain records
  • name, address, telephone number, DOB, gender
  • individual history like PMH, allergies, drug reactions
  • pharmacist comments relevent to therpay
  • only applies to Medicaid patients
156
Q

What act defined a dietary supplement?

A

Dietary Supplement Health and Education Act (DSHEA)

157
Q

What is a definition of a dietary supplement?

A

product (other than tobacco) intended to supplement the diet that contains one or more of the following
- a vitamin
- a mineral
- an herb or other botanical
- an amino acid

158
Q

What is required on all dietary supplement labels?

A
  • name of the product and the phrase (dietary supplement)
  • quantity of the contents
  • manufacturer’s, packer’s, or distributor’s name and address
  • directions for use
  • supplemental facts panel containing serving size, list of dietary ingredients, amount per serving size, and percent daily value if established
159
Q

What types of claims can manufacturers make about dietary suppolements

A
  • health claims
  • nutrient content claim
  • structure function claim
160
Q

Health Claim

A

a relationship between a product and its potential impact on approved disease state or condition

161
Q

Nutrient Content Claim

A
  • relative description of the nutrient or dietary substance in the product
162
Q

Structure Function Claim

A
  • description of maintaining proper body function independent of specific disease states
163
Q

Which dietary supplement claims must be FDA approved

A
  • health claim
  • nutrient content claim
164
Q

Which dietary supplement claim does not need FDA approval?

A
  • structure function claim
165
Q

What motivated Congress to pass the 1987 Prescription Drug Marketing Act (PDMA)

A

counterfeit ovulen 21

166
Q

What was the goal of the Prescription Drug Market Act

A

established procedures, requirements, and minimum standards for the distribution of prescription drugs and drug samples

167
Q

What are the four main aspects of the PDMA

A
  • reimportation
  • preferential pricing
  • samples and coupons
  • wholesale licensure
168
Q

What was discussed under the reimporation section of the PDMA

A
  • drug cannot be reimported into the US unless reimported by drug manufacturer or for emergency use after FDA review
  • bans importation of american made drugs from foreign countries, not importation of drugs from a foreign country
169
Q

American drugs bought in other countries at a discount and reimported into the US are considered what?

A

aldulterated

170
Q

What was discussed under the preferential pricing section of the PDMA

A

bans the sale, purchase, or trade of a prescription drug purchased at reduced price by hospital or other healthcare facility or donated or supplied to charities

171
Q

TRUE or FALSE: two entities who have access to the same preferential pricing can sell or trade with one another

172
Q

What was discussed under the samples and coupons section of the PDMA

A

bans the sale, purchase or trade of a drug sample or drug coupon, and bans counterfeiting of drug coupons

173
Q

How can samples and coupons be requested?

A
  • practitioners must ask for drug samples in writing
  • community pharmacies cannot have drug samples at any time
  • established recordkeeping, storage, and handling requirements for drug sample
174
Q

Are OTC drugs and starter packs considered sample?

175
Q

What was discussed under the wholesaler section of the PDMA

A

states were required to license wholesalers

176
Q

How long are records related to the PDMA kept?

177
Q

What is the whistleblower award?

A

$125,000 awarded for reporting someone violating PDMA

178
Q

What was passed to further increase supply chain security?

A

Drug Supply Chain Security Act (DSCSA)

179
Q

What became required after the passing of the DSCSA

A
  • barcodes or QR codes to prescription packages to allow better tracing and verification
  • pharmacies must track specific lot numbers throughout filing process
180
Q

When do manufacturers and wholesalers have to verify the legitimacy of products in question when inquired by a pharmacy?

A

within 24 hours

181
Q

When do illegitimate products have to be brought to the FDA when discovered?

A

within 24 hours

182
Q

How long must product tracking records under DSCSA be kept?

A

6 years (for all parts of the supply chain)

183
Q

NDC First 5 numbers

A

identify the manufacturer, assigned by FDA

184
Q

NDC Second 4 numbers

A

drug, strength, dosage form, and formulation of the product, assigned by the manufacturer

185
Q

NDC last 2 numbers

A

identify the package size, assigned by the manufacturer

186
Q

Who regulates prescription drug advertising?

187
Q

Who regulates nonprescription drug advertising

188
Q

Advertising to professionals must include

A
  • established name
  • formula of the drug
  • adverse event information
  • contraindications
  • effectiveness
189
Q

If information advertised to professionals is false, misleading, or biased in its discussion of adverse effects as compared to effectiveness, it is what?

A

misbranded

190
Q

How many standards does DTC adversing have to comply with?

191
Q

What are the 5 DTC advertising standards

A
  • consumer friendly language
  • appropriate audio
  • audio and text (tv)
  • text must be readable (tv)
  • free of audio or visual elements that may interfere with the comprehension of the major statement
192
Q

off label use

A

indication other than that approved by the FDA and thus not included in the approved drug labeling

193
Q

What is required of off label advertising

A

any information must be complete, peer reviewed journal articles published outside of company influence

194
Q

In order to diseeminate journal articles, any company that wants to advertise off label indications must do what

A
  • have applied for approval for that indication
  • submit a copy of the information and any clinical trial data the company has at least 60 days before disseminating
195
Q

What documents need to be included when disseminating journal articles for off label advertising

A
  • a disclosure noting the information has not yet been approved
  • a copy of the official labeling for the product
  • any other products that have been approved for off-label use
  • the funding source for the studies relating to the use
  • a bibliography of publications relating to the use
196
Q

What are the three covered entities of HIPAA

A
  • health care providers
  • health plans
  • health care clearinghouses
197
Q

Health care providers (HIPAA)

A
  • who electronically transmit any health information
  • individual or group providers
198
Q

Health plans (HIPAA)

A
  • health insurance
  • government payers (Medicare/Medicaid)
  • HMOs
199
Q

Health Care Clearinghouses
(HIPAA)

A

groups that process PHI on behalf of another entity (PBM, EHRs)

200
Q

What are 4 rules related to HIPAA

A
  • privacy
  • security
  • breach notification
  • enforcement
201
Q

What is considered PHI

A

Information related to:
- individuals past, present or future physical or mental health or condition
- provision of health care to the individual
- past, present, or future payment for the provision of health care to the individual

202
Q

Is de-identified health information PHI

203
Q

When must a covered entity disclose PHI

A
  • individuals requesting access to their own PHI
  • HHS when it is undertaking an investigation or review or enforcement action
204
Q

A covered entity may disclose PHI for what reasons

A
  • treatment, payment, and health care operations
  • to the individual
  • for an opportunity to agree or object
  • incidental use and disclosure
  • public interest
  • limited data set
205
Q

HIPAA Permitted Uses and Disclosures: Treatment

A

provision, coordination, or management of health care and related services for an individual by one or more health care providers

206
Q

HIPAA Permitted Uses and Disclosures: Payment

A

acitivites of a health plan to obtain premiums, determine or fulfill responsibilities for coverage and benefits, and furnish or obtain reimbursement

207
Q

HIPAA Permitted Uses and Disclosures: Health Care Operations

A
  • quality assessment and improvement activities
  • medical reviews, audits, legal services
208
Q

What does the HIPAA Security Rule require?

A
  • covered entities to maintain reasonable and appropriate administrative, technical, and physical safeguards of electronic PHI
209
Q

HIPAA Breach Notifcation: < 500 people

A
  • report breach to secretary of HHS within 60 days of the end of the calendar year in which the breach was discovered
210
Q

HIPAA Breach > 500 individuals

A
  • report breach to secretary of HHS within 60 days from discovery of breach
  • report breach to prominent media outlets serving the state or jurisdiction
  • reports available to public
211
Q

Drug monographs within the USP have what?

A

the force of law

212
Q

Not following drug monographs within the USP leaves a drug what?

A

adulterated or misbranded

213
Q

TRUE or FALSE: the information published by the USP regarding the appropriate means for drug prep and storage has force of law

A

NO, not federally

214
Q

What is USP 795

A

nonsterile compunding

215
Q

What does USP 795 require

A

BUDs to be assigned to nonsterile products

216
Q

What does USP 797 cover

A

sterile compounding requirements, including personnel, training, facilities, environmental monitoring, and storage and testing of finished products

217
Q

What does USP 800 cover

A
  • discusses the handling of hazardous drugs in healthcare settings
218
Q

What are the expiration date requirements for USP

A
  • expiration date is the last date the product will meet the requirements of the USP monograph for strength and stability
219
Q

What is a BUD

A

date after which a product should not be used

220
Q

Repackaging

A
  • location takes a drug from a manufacturer’s bottle and puts it into new package without doing other things
221
Q

What must repackaging meet?

A

all provisions of FDCA

222
Q

TRUE or FALSE: taking a drug out of a stock bottle and placing into a prescription bottle for dispensing meets the criteria for repackaging

223
Q

What are the FDA exemptions of repackaging?

A
  • prescription drug product on shortage list
  • repackaged under direct supervision of licensed pharmacist
  • if repackaged by pharmacy, only distributed upon receipt of a valid prescription for an individual patient
  • repackaged product is assigned a BUD as described in the repackaging guidance
224
Q

Non aquous formulation BUD

A

no more than 6 months

225
Q

water containing oral formulation BUD

A
  • no more than 14 days
226
Q

water containing topical, mucosal, semisolid formulation

A

no more than 30 days

227
Q

How are pharmacy inspections conducted

A
  • routine inspection (periodically at random)
  • inspection triggered by knowledge, suspicion, or formal complaint of wrongdoing that may be a danger to public safety
228
Q

Who are exempted from FDA inspections per FDCA

A

pharmacies unless the pharmacy manufacturers, prepares, or compounds drugs or devices

229
Q

Why would the FDA inspect a pharmacy

A

to determine if they manufacture drugs and to verify compounding is done appropriately

230
Q

How may FDA inspectors request entry to a pharmacy

A

Notice of Inspection (FDA form 482) and credentials

231
Q

What does the DEA inspect

A

any place where controlled substances are kept

232
Q

What does a DEA inspector look for?

A
  • may examine records and reports related to controlled substances
  • inspect the premise
  • inventory controlled substances
233
Q

Does the DEA need a warrant?

A

no, but you can refuse t hem entry or revoke consent at any time and require a warrant

234
Q

When requesting inspection, a DEA inspector must

A
  • state the purpose of their inspection
  • show their credentials
  • provide written notice of inspection to the pharmacy owner or pharmacist in charge
235
Q

DEA NOI Rights

A
  • require the DEA to get AIW
  • to refuse inspection (at which they will get a AIW)
  • anything incriminating can be seized and used against you
  • will get a copy of the NOI
  • may withdraw consent to inspection
236
Q

Who can sign an NOI

A

owner, operator, or agent in charge

237
Q

AIW

A

provided for anything considered a valid public interest (low bar to clear)

238
Q

Search warrant

A

provided if an officer can convince a judge that a reasonable person would believe that a crime has been or will be committeed on the premises to be serached or that evidence related to a crime exists at the premises

239
Q

When can AIWs be served

A

only during regular business hours

240
Q

When can search warrants be served

241
Q

Are there situations where a warrant is not required

A

YES (consent, imminent danger, emergency situation)

242
Q

Can you say no to a BoP inspection

243
Q

Do BoP inspectors need a warrant

244
Q

Orange Book

A

The Approved Drug Products with Therapeutic Equivalence Evaluations provides equivalancy rating for the product

245
Q

RLD

A
  • original brand name product in Orange Book
  • utilized by the generics when submitting an abbreviated new drug application
246
Q

RS

A

the product to which generic has to demonstrate equivalency

247
Q

To be therapeutically equivalent, the product must be both

A

pharmaceutically equivalent and bioequivalent

248
Q

phamaceutical equivalence

A
  • active ingredient
  • dosage form
  • strength
  • route
  • labeling
249
Q

Bioequivalence

A
  • in vivo results (human)
  • in vitro results (kinetics, dynamics, clinical effects)
250
Q

TE Code First Letter

A

indicates relevant therapeutic equivalence code

251
Q

TE Code Second Letter

A

indicates dosage form

252
Q

Three Character TE CODE

A

Drugs with a three-character code are considered therapeutically
equivalent only to other drugs with the same three-character code
(AB1 = AB1, AB1 ≠ AB2)

253
Q

TE Code A

A

no concern related to pharmaceutical equivalence or bioequivalence if first letter

254
Q

TE Code B

A

not therapeutically equivalent if first letter

255
Q

What was the first federal law regulating medications?

A

1906 Pure Food and Drug Act

256
Q

What did the Pure Food and Drug Act do?

A
  • recognized the US pharmacopeia and NF as standard drug references
  • defined misbranding and adulteration and assigned penalties to each practice
  • established Bureau of Chemistry in the US Department of Agriculture as reasonable party of enforcement
257
Q

What does the Official Compendia consist of?

A

USP, NF, HPUS

258
Q

Product contains any poisonous or insanitary ingredients or lacks adequate controls in manufacture

A

adulterated

259
Q

strenght, quality, or purity differs from the official compendium

A

adulterated

260
Q

strength differs from representation if not found in official compendium

A

adulterated

261
Q

product mixed with another substance to reduce its quality or strength or substituted altogether

A

adulterated

262
Q

delayed, denied, or limited inspection, or refusual to permit entry or inspection

A

aldulterated

263
Q

What are the only two banned devices

A

prosthetic hair fibers and powered gloves

264
Q

What makes a device adulterated

A
  • not in conformity with performance standards
  • certain class III devices that do not have appropriate approval for use
  • banned devices
  • manufacture, packaging, or instillation of device not conforming
  • failure to comply with requirements under which a device was exempted for investigational use
265
Q

Class I Device

A

not used for supporting human life and/or preventing impairment of human health, and do not present a potential unreasonable risk of illness or injury

266
Q

Class II device

A

moderates risk to use, require special controls to assure safety and effectiveness of devices

267
Q

Class III devices

A

high risk to use, supports or sustain human life or preventing impairment of human health and do present a potential unreasonable risk of illness or injury

268
Q

labeling that is false or misleading

A

misbranding

269
Q

labeling that does not contain the manufacturer, packer, distributor, and an accurate statement of the quality of the contents in terms of weight, measure, or count

A

misbranding

270
Q

require informationis not predominantly displayed or clearly stated

A

misbranding

271
Q

established name not included and at least 1/2 as large as the proprietary name

A

misbranding

272
Q

directions and required warnings not included on label

A

misbranding

273
Q

Established name

A

generic name

274
Q

proprietary name

A

brand naem

275
Q

Not in compliance with official compendia standards for packaging

A

misbranding

276
Q

product is liable to deteriorate unless packaged appropriately and notes an expiration date

A

misbranding

277
Q

if the drug container is developed in a misleading way or is an imitation of another drug

A

misbranding

278
Q

if use of the drug prescribed is dangerous to health

A

misbranding

279
Q

if an ingredient is a color additive only and not in compliance labeled appropriately

A

misbranding

280
Q

if advertisments do not include required information

A

misbranding

281
Q

if packaging safety requirements are not met

A

misbranding

282
Q

if REMS required and not appropriately addressed

A

misbranding

283
Q

if a product identifier is required and not included (Rx only, Controlled Substance Marking)

A

misbranding

284
Q

Pure Food and Drug Act United States v Johnson

A

supreme court ruled that the Pure Food and Drug Actt only prevented false statements on the drug’s identify, and not false or misleading efficacy claims

285
Q

Which act prohibits manufacturers from intentionally misleading claims about a drugs effectiveness

A

The 1912 Sherley Amendment

286
Q

To address the Supreme Court Ruling in US v Johnson, what did congress pass

A

The Sherley Amendment in 1912

287
Q

What was a limitation of the Sherley Amendement

A

the onus was on the government to prove intent, which made this amendement extremely difficult to enforce

288
Q

What act permitted FDA control over cosmetics and therapeutic devices

A

Federal Food, Drug, and Cosmetic Act

289
Q

Whaat did the FDCA do

A
  • required new drugs to be shown safe before marketing
  • repealed Sherley Amendment requirement to prove intent to defraud in drug misbranding cases
  • authorized factory inspection
  • required selected dangerous drugs to be administered under the direction of a qualified expert
290
Q

What is a definition of a drug according to the FDCA

A
  • articles recognized in the official compendia
  • intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals
  • articles other than food intended to affect the structure or any functions of the body of man or other animals
291
Q

Alberty Food Products v US

A

in order for labeling of a drug to bear adequate directions for use, it must state the purposes and conditiosn for which the drug was intended and sufficient information to enable a layman to intelligently and safely attempt self medication

292
Q

Durham Humphry Amendment

A
  • OTC meds could be labeled witth adequate directions for use
  • legend meds had to be dispensed under the supervision of a health practitioner as a prescription drug and carry statement “caution: federal law prohibits dispensing without a prescription”
  • verbal transmission of prescriptions and refills for prescription drug